PKBDO2512RXGQ
PKBDO2512RXGQ
released
Clinical summary
Diabetes status
Control Without Diabetes
BMI
28.4
HbA1c %
5.6
C-Peptide (ng/ml)
—
Diabetes duration
-
Demographics
- Age (y)
- 55
- Gender
- Male
- Genetic Sex
- Male
- Ethnicity
- White
- Predicted genetic ancestry
- African (2%), Admixed-American (3%), East-Asian (2%), European (93%)
Additional clinical
- Diabetes (ontology)
- No ontology term
- T1D stage
- No sufficient information to derive
- Derived diabetes status
- Normal
- Family history relationship
- -
- Living donor
- No
- Cause of death
- Cerebrovascular/stroke
- Hospital stay (h)
- 71
- Medication
- -
HLA typing
Status: X/X
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 2 | 26 | OPO |
| B | 44 | 55 | OPO |
| C | 05 | 09 | OPO |
| Bw4 | 1 | — | OPO |
| Bw6 | 1 | — | OPO |
| DR | 11 | 13 | OPO |
| DR51 | 0 | — | OPO |
| DR52 | 1 | — | OPO |
| DR53 | 0 | — | OPO |
| DQ | 7 | 7 | OPO |
Data available
Islet
scRNAseqAccess dataset
Supplementary
IIDP
IIDP:SAMN12673306, HIPP:HIPP273
- Pancreas tissue available
- No
- Other tissues
- —
External resources
IIDP:SAMN12673306
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
